grantGrants.gov

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Organization National Institutes of HealthPosted 4 May 2026Deadline 10 Nov 2026
HHS-NIH1193.853synopsis
Sign up free to applyFull description · apply link · all types
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Explore more

🏷 More HHS-NIH11 opportunities🏷 More 93.853 opportunities🏷 More synopsis opportunities🏢 All Grants.gov opportunities

Full Description

Opportunity Number: RFA-NS-26-001 Document Type: synopsis CFDA Numbers: 93.853

Read the full description

Sign up freeFree account · No credit card required
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) — National Institutes of Health | Dev Procure